Build a Targeted Biomarker Strategy for Your Program

From chemistry to drug discovery. Postdoc Gulshan Amrahova on molecular glues, letting your interests evolve, and building skills beyond your specialty.

Eight research projects at Lund University and Malmö University will share SEK 20 million from the Mats Paulsson Foundations. The grants will support work on new cancer treatments, universal blood, and better protection against cardiovascular disease.

Saniona has agreed to sell its entire shareholding in AstronauTx to existing AstronauTx investors for GBP 3.36 million (SEK 44.5 million) in cash. The proceeds will help fund Saniona’s two lead programs as they move into Phase 1.

IRLAB Therapeutics is redirecting its resources toward revenue-generating partnerships for its existing project portfolio and plans to cut about ten positions, mainly in early-stage R&D. The company also says that new partnership agreements are now less likely to be signed before the end of 2026.

Lundbeck has raised its financial guidance for 2026 and now expects revenue growth of 11–12% at constant exchange rates, up from 7–9%.

Pharmaceutical distributor Oriola has lowered its outlook for 2026 and no longer expects adjusted EBITDA to increase from last year. The company now expects adjusted EBITDA to be at the same level as or higher than in 2025, when it was EUR 35.1 million.

Leeds Cancer Centre has treated the first patient using new reirradiation functionality in RaySearch Laboratories’ RayStation treatment planning system. The tools were developed over more than a decade of collaboration with Leeds Teaching Hospitals NHS Trust and the University of Leeds.